Please Wait a Moment
X

Articles

22Apr

Update on CTS Implementation of the Grifols Procleix Ultrio Elite Assay

22 Apr, 2020 | Return|

In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.

 

Click here for all the details: Communications

Related

Reminder-Confirmatory Algorithm and Assay Changes Effective September 30, 2019

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

Read More >

New Online Learning Center with New Content

The new online Learning Center with new content can still be found under the “Training” folder on ...

Read More >

CTS Dallas and Phoenix Labs Implements WNV Testing on the Panther

CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...

Read More >

Emailing Daily Shipment Schedules to CTS

CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...

Read More >

Discontinue HIV-1 IFA Confirmatory Test

CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...

Read More >

Reminder- Check flights and cargo hours for the Christmas holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for hol...

Read More >